Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
  1. 4 Open-market sale Chief Commercial Officer sold 3,941 shares at $35.08 ($138,250)
  2. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $35.00 ($350,000)
  3. 4 Open-market sale VP of Operations sold 1,680 shares at an average $31.98 ($53,734)
  4. 4 Exercise or conversion VP of Quality & Engineering acquired 3,200 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale VP of Operations sold 1,680 shares at $28.33 ($47,594)
  8. 4 Exercise or conversion VP of US Regulatory & FDA Rel. acquired 2,206 shares (option exercise)
  9. 4 Open-market sale Chief Commercial Officer sold 5,152 shares at $35.10 ($180,835)
  10. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $35.00 ($350,000)
  11. 4 Open-market sale VP of Operations sold 1,680 shares at an average $33.65 ($56,538)
  12. 4 Open-market sale Chief Commercial Officer sold 3,899 shares at $35.06 ($136,699)
  13. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
  14. 4 Exercise or conversion Chief Financial Officer acquired 5,714 shares (option exercise)
  15. 4 Open-market sale VP of Operations sold 1,680 shares at $26.01 ($43,697)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 18 · 358 filings